Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- DSM Reports Q3 Results
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- Arcadia Biosciences Receives NIH Research Grant to Develop Soybean Varieties with Desired Levels of Isoflavones
Company will use its proprietary TILLING(R) advanced screening technology to develop soybean plants that, through genetic variation, contain various levels of soy isoflavones, ranging from very high to very low or none at all.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- TR International Signs Exclusive Distributorship with Shanghai Jiubang for Pyridoxal-5-Phosphate
Company announces that it has acquired the exclusive distribution rights from Shanghai Jiubang for Pyridoxal-5-Phosphate in the U.S. marketplace.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Blue California Appointed Exclusive Distributor of Water-Soluble Coenzyme Q10
Company has been appointed as the exclusive distributor for a new, water-soluble, coenzyme Q10 product line, CoQ10-WS(TM), manufactured in Japan.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Nutrition 21 Announces Management Changes
Company announces the resignation of Gail Montgomery as a director and officer of the Company, as well as announcing that Paul Intlekofer has been elected Chief Operating Officer and Chief Financial Officer.
- Wild Oats Markets, Inc. Reports Third Quarter 2005 Results
Company reports a sales increase to $278.5
million, compared to $250.7 million prior year, with a comparable stores increase of 6.1%. Net income was $82,000, or $0.00 per diluted share, compared with a net loss of $7.1 million, or $0.25 per diluted share in the same period last year.
- Wild Oats Markets, Inc. Reports Third Quarter 2005 Results
Company reports a sales increase to $278.5
million, compared to $250.7 million prior year, with a comparable stores increase of 6.1%. Net income was $82,000, or $0.00 per diluted share, compared with a net loss of $7.1 million, or $0.25 per diluted share in the same period last year.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- LycoRed Acquires Buckton Scott Nutrition Business
LycoRed Corp. has acquired the assets and business of Buckton Scott Nutrition, Fairfield, N.J., a subsidiary of Buckton Scott Group.
- Ideasphere Completes Deal to Acquire Non-Ephedra Metabolife Assets
Company announces that it has closed a transaction to acquire certain assets of Metabolife International, Inc., including the company's core non-ephedra brands, Metabolife Ultra, Metabolife Complete, Metabolife Ultra Caffeine Free and Metabolife Green Tea Formula; a state-of-the-art powder and tablet manufacturing facility located in Orem, Utah; and a distribution center in Memphis.
- Ideasphere Completes Deal to Acquire Non-Ephedra Metabolife Assets
Company announces that it has closed a transaction to acquire certain assets of Metabolife International, Inc., including the company's core non-ephedra brands, Metabolife Ultra, Metabolife Complete, Metabolife Ultra Caffeine Free and Metabolife Green Tea Formula; a state-of-the-art powder and tablet manufacturing facility located in Orem, Utah; and a distribution center in Memphis.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
KAILUA KONA, Hawaii, Nov 03, 2005 (BUSINESS WIRE) -- Cyanotech Corporation (CYAN), a world leader in producing high-value nutrition and health products from microalgae, today announced financial results for the second quarter of its fiscal year 2006, ended September 30, 2005. Sales for the second quarter of fiscal 2006 were $2,517,000, a decrease of 16% and 17% compared to sales of $2,998,000 for the same period of the prior fiscal year and $3,029,000 for the prior sequential quarter, respectively. The decrease in sales resulted from lower order levels for Spirulina Pacifica(R) products and reduced demand for NatuRose(R) from the Japanese aquaculture market, offset in part by slightly higher sales of BioAstin(R) natural astaxanthin for the human nutritional supplement market.
Gross profit for the second quarter of fiscal 2006 was $581,000, with gross profit margin of 23%, compared to a gross profit of $1,054,000 and gross profit margin of 35% reported for the same quarter of the prior year. Gross profit and gross profit margin for the quarter ended September 30, 2005 were impacted by higher per unit natural astaxanthin production costs due to the Company's decision to reduce production in response to overall order levels.
Net loss for the second quarter was $321,000, or ($0.02) per diluted share, compared to net income of $121,000, or $0.01 per diluted share for the same quarter of the prior year and net income of $153,000, or $0.01 per diluted share for the prior sequential quarter.
"Our lower overall revenue during the second quarter of fiscal 2006 was due largely to fluctuation in the ordering pattern of our spirulina customers as well as to reduced orders for NatuRose from the Sea Bream market in Japan," said Cyanotech's Chairman, President and Chief Executive Officer, Gerald R. Cysewski. "As a consequence of the present state of the Japan aquaculture market we are expanding into other areas such as tropical fish. There are also studies underway to determine the potential of NatuRose for decreasing mortality and improving absorption of food by young fish. Such economic benefits for the aquaculture market would expand NatuRose's value beyond pigment enhancement.
"Despite lower order levels from our two largest BioAstin customers, sales of BioAstin increased overall reflecting our new wholesale, business-to-business marketing focus," Dr. Cysewski continued. "Our BioAstin natural astaxanthin is an ingredient in health formulations from nearly 40 manufacturers, with customers such as Now Foods, Health Plus, Twin Laboratories and Jarrow Formulas, among others." Dr. Cysewski added further, "We have launched a new corporate website with additional information thereby increasing the effectiveness of our marketing activity."
For the first six months of fiscal 2006 the Company reported sales of $5,546,000, a slight decrease from sales of $5,705,000 reported for the comparable period of the prior fiscal year. Gross profit for the first six months of fiscal 2006 was $1,606,000 with gross profit margin of 29%, compared to gross profit of $1,941,000 and gross profit margin of 34% for the comparable period of the prior fiscal year. Gross profit and gross profit margin were impacted by higher per unit natural astaxanthin production costs due to the Company's decision to reduce production in response to market conditions. For the first six months of fiscal 2006 the Company reported a net loss of $168,000, or ($0.01) per diluted share compared to net income of $234,000, or $0.01 per diluted share reported for the comparable period of the prior fiscal year.
The Company's cash and cash equivalents increased to $2,054,000 from the March 31, 2005 balance of $2,005,000. Working capital remained adequate, increasing $210,000 from $5,102,000 at March 31, 2005 to $5,312,000 at September 30, 2005.
About Cyanotech
Cyanotech Corporation, the world leader in microalgae technology, produces BioAstin(R) Natural Astaxanthin and Hawaiian Spirulina Pacifica(R) -- all natural, functional nutrients that enhance human health and nutrition, providing significant antioxidant, anti-inflammatory and immune response benefits. NatuRose(R) Natural Astaxanthin is a natural pigment source that also promotes animal health and nutrition, primarily in aquaculture. Phycobiliproteins are fluorescent pigments used in medical diagnostic testing and research. Cyanotech produces these products from microalgae grown at its 90-acre facility in Hawaii using patented and proprietary technology and distributes them to nutritional supplement, nutraceutical, cosmeceutical, and animal feed makers and marketers in more than 30 countries worldwide. Cyanotech was the first microalgae company in the world to obtain ISO 9001:2000 certification. Corporate data and product information are available at www.cyanotech.com.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995
Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, forecasts of sales in future periods, changes in sales levels to our largest customers, weather patterns, production problems caused by contamination, risks associated with the acceptance of new products, competition, foreign exchange fluctuations, government regulation, and other factors more fully detailed in the Company's recent Form 10-Q and annual form 10-K filings with the Securities and Exchange Commission.
Cyanotech Corporation will hold a conference call on Thursday, November 3, 2005 at 5:30 p.m. Eastern Time to be broadcast live over the Internet. It can be accessed by linking through the Investor Broadcast Network's VCall website at www.vcall.com or through Cyanotech's website, http://www.cyanotech.com. To access the simultaneous webcast, please go to either website at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call and will be archived for a period of one calendar year. |